HISAMITSU PHARMACEUTICAL CO.,INC. [4530.T]

TOKYO, Apr 17 (Pulse News Wire) – HISAMITSU PHARMACEUTICAL CO.,INC. (4530.T) announced plans to conduct a share consolidation that will result in the company's delisting from the Tokyo Stock Exchange.

The company will consolidate shares at a ratio of 182:1.

An extraordinary general meeting of shareholders to approve the consolidation is scheduled for April 17, 2026.

The company's shares are expected to be delisted on May 11, 2026.

Original Disclosure (PDF)

🟢 Confidence: High AI-translated content.